GR81746B - - Google Patents

Info

Publication number
GR81746B
GR81746B GR73619A GR840173619A GR81746B GR 81746 B GR81746 B GR 81746B GR 73619 A GR73619 A GR 73619A GR 840173619 A GR840173619 A GR 840173619A GR 81746 B GR81746 B GR 81746B
Authority
GR
Greece
Application number
GR73619A
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of GR81746B publication Critical patent/GR81746B/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0821Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0812Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
GR73619A 1983-01-27 1984-01-25 GR81746B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH45383 1983-01-27

Publications (1)

Publication Number Publication Date
GR81746B true GR81746B (el) 1984-12-12

Family

ID=4187370

Family Applications (1)

Application Number Title Priority Date Filing Date
GR73619A GR81746B (el) 1983-01-27 1984-01-25

Country Status (12)

Country Link
EP (1) EP0115472A3 (el)
JP (1) JPS59141559A (el)
KR (1) KR840007571A (el)
AU (1) AU2383884A (el)
DD (1) DD216005A5 (el)
DK (1) DK35884A (el)
FI (1) FI840260A (el)
GR (1) GR81746B (el)
IL (1) IL70772A0 (el)
NO (1) NO840310L (el)
PT (1) PT78007B (el)
ZA (1) ZA84560B (el)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE943625C (de) * 1943-06-28 1956-05-24 Ferguson Harry Inc Seitensteuerungseinrichtung fuer ein landwirtschaftliches Schlepperanbaugeraet
JPH0696574B2 (ja) * 1987-09-16 1994-11-30 三菱化成株式会社 4−ピペリジンカルボキサミド誘導体
JPH0696575B2 (ja) * 1987-09-17 1994-11-30 三菱化成株式会社 4−アミノピリジン誘導体及びその酸付加塩
JP2997488B2 (ja) * 1989-12-25 2000-01-11 興研株式会社 腫瘍細胞増殖抑制剤
CA2172125A1 (en) * 1993-09-30 1995-04-06 S. Jane Desolms Inhibitors of farnesyl-protein transferase
JP2002538151A (ja) 1999-03-02 2002-11-12 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド カテプシンの可逆的インヒビターとして有用な化合物
US6420364B1 (en) 1999-09-13 2002-07-16 Boehringer Ingelheim Pharmaceuticals, Inc. Compound useful as reversible inhibitors of cysteine proteases
US6825229B2 (en) 2002-03-07 2004-11-30 Blanchette Rockefeller Neurosciences Institute Methods for Alzheimer's Disease treatment and cognitive enhancement
US20050065205A1 (en) 2002-03-07 2005-03-24 Daniel Alkon Methods for Alzheimer's disease treatment and cognitive enhance
TW201207390A (en) 2004-05-18 2012-02-16 Brni Neurosciences Inst Method for screening agent for antidepressant activity
JP5323481B2 (ja) 2005-07-29 2013-10-23 ブランシェット・ロックフェラー・ニューロサイエンスィズ・インスティテュート 長期記憶を増強するための、pkc賦活薬の単独またはpkc阻害剤と組み合わせての使用
CA2674773A1 (en) 2007-02-09 2008-08-21 Blanchette Rockefeller Neurosciences Institute Therapeutic effects of bryostatins, bryologs, and other related substances on head trauma-induced memory impairment and brain injury

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT360980B (de) * 1976-01-14 1981-02-10 Pliva Pharm & Chem Works Verfahren zur herstellung von n-alkylamiden des 2-oxo-1-pyrrolidins
GB1539817A (en) * 1976-10-22 1979-02-07 Ucb Sa N-substituted lactams

Also Published As

Publication number Publication date
PT78007B (en) 1986-06-18
JPS59141559A (ja) 1984-08-14
PT78007A (en) 1984-02-01
NO840310L (no) 1984-07-30
ZA84560B (en) 1984-09-26
IL70772A0 (en) 1984-04-30
DD216005A5 (de) 1984-11-28
DK35884A (da) 1984-07-28
DK35884D0 (da) 1984-01-26
KR840007571A (ko) 1984-12-08
EP0115472A3 (de) 1985-10-02
AU2383884A (en) 1984-08-02
FI840260A (fi) 1984-07-28
FI840260A0 (fi) 1984-01-23
EP0115472A2 (de) 1984-08-08

Similar Documents

Publication Publication Date Title
FR2539383B1 (el)
GR81746B (el)
FR2540911B1 (el)
AT378328B (el)
FR2543050B3 (el)
GR81747B (el)
FR2541505B3 (el)
DE8315982U1 (el)
DE3321609C2 (el)
GR71376B (el)
DE8323785U1 (el)
DE8317392U1 (el)
GR71253B (el)
BG44651A1 (el)
BG45041A3 (el)
BG45222A1 (el)
BG44569A1 (el)
BG45098A1 (el)
BG44655A1 (el)
BG44763A1 (el)
BG44795A1 (el)
BG44873A3 (el)
BG44874A3 (el)
BG45096A1 (el)
BG44707A3 (el)